Debt to EBITDA ratio Analysis of Sarepta Therapeutics Inc - Deep Dive
Birds's Eye
Fundamentals
Fundamentals
Technicals
MovingAverage
Candlestick
PivotPointDebt to EBITDA of SRPT
Dec-23-2.01Very Poor Debt to EBITDA | Dec-22-2.41Very Poor Debt to EBITDA | Growth16.35% |
Debt to EBITDA Analysis of Sarepta Therapeutics Inc
| Debt to EBITDA Ratio of SRPT has grown by 16.35 % Compared to previous Financial Year. |
| Debt to EBITDA Ratio with value of -1.06 was highest in Year Dec-19 in last Five Years. |
| Debt to EBITDA Ratio with value of -4.31 was lowest in Year Dec-21 in last Five Years. |
| Latest Debt to EBITDA Ratio with value of -2.01 is Greater than Average Debt to EBITDA of -2.42 in last five years. |
Other Debt to EBITDA Related Info of SRPT that may interest you.
Sarepta Therapeutics Inc Overview
| Code | Price | Previous Price | Price Change | Sector |
|---|---|---|---|---|
| SRPT | 129.86 | 124.45 | 4.35 % | Biotechnology |
Defination of Debt to EBITDA
The Debt to EBITDA Ratio is a solvency metric that measures the company's ability to meet its debt obligations by earnings before covering its interest, taxes, depreciation, and amortization. more ..
Debt to EBITDA Related Ratios
| CashFlowFromOperationToDebt | DebtToCapital | EVToEBITDA |
Tsr Stability Index
| Poor Stability Stock | |
FY - Historical Debt to EBITDA of Sarepta Therapeutics Inc
| Period | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 |
|---|---|---|---|---|---|---|---|
| Debt to EBITDA | -2.01 | -2.41 | -4.31 | -2.30 | -1.06 | -1.75 | -12.40 |
| Change | 16.35 % | 44.18 % | -87.37 % | -117.75 % | 39.67 % | 85.88 % | -19993.99 % |
FY Chart of Debt to EBITDA of Sarepta Therapeutics Inc
Note : All Data Generated at the End of Trading Hours (EOD Data)